Evidence map›Paper›PMID 27417512›Full record

ReviewCurrent psychiatry reports2016

An Update on the Use of Sedative-Hypnotic Medications in Psychiatric Disorders.

Shane Creado, David T Plante

Abstract readReview
In one paragraph

Review in Current psychiatry reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Chronic hypnotic use at 10 years-does the brand matter?European journal of clinical pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Shane CreadoDepartment of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
David T PlanteDepartment of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. dplante@wisc.edu.
University of Wisconsin–Madison · USWisconsin Division of Public Health · US

Funding

Hypersomnia in Major Depressive Disorder: a high-density EEG investigationK23MH099234 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI PLANTE, DAVID T · 2013 to 2017
$972k
NIMH NIH HHS K23 MH099234
6 · The paper itself

Abstract

Sleep disturbance is a common clinical problem experienced by patients with a wide range of psychiatric disorders. Accumulating evidence has demonstrated that insomnia is a comorbid process that affects the course and treatment of a number of forms of mental illness. The efficacy and safety of sedative-hypnotic medications have largely been established in patients who do not have comorbid psychiatric disorders, underscoring the need for further research in this sphere. This review summarizes pertinent findings in the recent literature that have examined the role of hypnotic medication in the treatment of psychiatric illness, and highlights potential areas that may prove fruitful avenues of future research.

Indexed as

Mental DisordersSleep Initiation and Maintenance DisordersComorbidityHumansHypnotics and SedativesMedication Therapy ManagementSleepTreatment OutcomeHypnotics and SedativesHypnoticInsomniaPsychiatricSedativeSleep

Identifiers

PMID27417512
PMCPMC4980146
OpenAlexW2473131913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.